Page 28 - Immunization Practices News Today

An overview of updated CDC ACIP recommendations for COVID-19 vaccines available through commercial channels for the 2023-2024 season.

Penbraya (Pfizer Inc) is the first and only approved pentavalent vaccine that confers protection against the most common meningococcal serogroups—A, B, C, W-135, and Y, in individuals 10 through 25 years of age.

By Stephen Nakrosis Pfizer said the Food and Drug Administration approved Penbraya, a vaccine preventing the five most common serogroups causing meningococcal disease, for adolescents and...

Study of shingles vaccine take-up co-authored by Brandyn Churchill, assistant professor of resource economics, provides key insights for COVID-19 vaccination rates.

CHICAGO The Illinois Department of Public Health (IDPH) said today that although data indicates COVID-19 hospitalizations are at a low level across the

Two new tools can prevent tens of thousands of hospitalizations and deaths

Findings may encourage increased pediatric vaccine uptake, researcher says

But another jab after 1 year proved less meaningful in AReSVi-006 trial

A misleading meme claims flu vaccines include dangerous ingredients, but most are not present and are safe in small amounts. Get the facts.

During a podcast hosted by Permanente Medicine, Sandra Fryhofer, MD, chair-elect of the Board of Trustees for the American Medical Association and a liaison to the CDC’s Advisory Committee on Immunization Practices, discussed the importance of vaccines for the fall and winter seasons.